We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC) (ECLIPSE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01082549
Recruitment Status : Completed
First Posted : March 8, 2010
Last Update Posted : March 17, 2016
Information provided by (Responsible Party):

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : April 2013
  Study Completion Date : April 2013
  Certification or Request for Extension to Delay Results Submission: February 17, 2016